GenEros Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

GenEros General Information

Description

Developer of therapeutics intended for the treatment of autoimmune diseases and cancer. The company offers molecular profiling for precision treatment, and leverages translational research collaborations, enabling immunology and oncology markets to access mechanism-driven, pathway-specific therapeutic solutions.

Contact Information

Website
www.generosbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 501, Building 4, Number 291, Fucheng Road
  • Xiasha Street, Qiantang District
  • Hangzhou, Zhejiang 341200
  • China
+86 180
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • Room 501, Building 4, Number 291, Fucheng Road
  • Xiasha Street, Qiantang District
  • Hangzhou, Zhejiang 341200
  • China
+86 180

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenEros Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Mar-2025 Completed Generating Revenue
4. Secondary Transaction - Private 24-Oct-2022 Completed Generating Revenue
3. Secondary Transaction - Private 02-Jun-2022 Completed Generating Revenue
2. Secondary Transaction - Private 21-Jan-2022 Completed Generating Revenue
1. Early Stage VC 28-Jul-2021 Completed Generating Revenue
To view GenEros’s complete valuation and funding history, request access »

GenEros Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BVCF Venture Capital Minority
Heda Ventures Venture Capital Minority
Cherami Investment Group Asset Manager Minority
To view GenEros’s complete investors history, request access »

Ready to get started?

Request a free trial

GenEros FAQs

  • When was GenEros founded?

    GenEros was founded in 2018.

  • Where is GenEros headquartered?

    GenEros is headquartered in Hangzhou, China.

  • What industry is GenEros in?

    GenEros’s primary industry is Drug Discovery.

  • Is GenEros a private or public company?

    GenEros is a Private company.

  • What is GenEros’s current revenue?

    The current revenue for GenEros is .

  • Who are GenEros’s investors?

    BVCF, Heda Ventures, and Cherami Investment Group have invested in GenEros.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process